MarketCap
Facebook
X
Telegram
scPharmaceuticals Operating Cycle | SCPH
Annual Operating Cycle scPharmaceuticals
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 447 | 542 | - | - | - | - | - | - | - | - | - | - | - | - |
Annual performance
Select metrics to display
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 542 | 447 | 495 |
Quarterly Operating Cycle scPharmaceuticals
| 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 356 | 468 | - | 530 | 561 | 547 | - | 617 | 1.35 K | 432 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Quarterly performance
Select metrics to display
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 1.35 K | 356 | 607 |
Operating Cycle of other stocks in the Biotechnology industry
| Issuer | Operating Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Sage Therapeutics
SAGE
|
408 | - | - | $ 527 M |  USA |
 |
Lineage Cell Therapeutics
LCTX
|
19.2 | $ 1.13 | 8.17 % | $ 260 M | USA |
 |
Paratek Pharmaceuticals
PRTK
|
337 | - | - | $ 121 M | USA |
 |
Eli Lilly and Company
LLY
|
433 | $ 1 437.4 | 0.36 % | $ 1.29 T | USA |
 |
Compugen Ltd.
CGEN
|
400 | $ 2.09 | -0.24 % | $ 195 M |  Israel |
 |
Crinetics Pharmaceuticals
CRNX
|
554 | $ 84.95 | 0.13 % | $ 7.99 B | USA |
 |
GeoVax Labs
GOVX
|
48.4 | $ 2.13 | -20.4 % | $ 2.04 M | USA |
 |
AVEO Pharmaceuticals
AVEO
|
263 | - | - | $ 521 M | USA |
 |
Seelos Therapeutics
SEEL
|
63.2 | - | -47.76 % | $ 6.27 M | USA |
 |
Celldex Therapeutics
CLDX
|
43.4 | $ 30.18 | -1.53 % | $ 2 B | USA |
 |
Moderna
MRNA
|
108 | $ 248.62 | -0.88 % | $ 96.7 B | USA |
 |
CollPlant Biotechnologies Ltd.
CLGN
|
233 | $ 3.96 | 1.41 % | $ 48.3 M | Israel |
 |
Nektar Therapeutics
NKTR
|
98 | $ 38.41 | 1.67 % | $ 648 M | USA |
 |
CorMedix
CRMD
|
439 | $ 5.31 | -2.23 % | $ 383 K | USA |
 |
XTL Biopharmaceuticals Ltd.
XTLB
|
214 | $ 1.66 | -2.64 % | $ 1.12 B | Israel |
 |
Deciphera Pharmaceuticals
DCPH
|
2.1 K | - | - | $ 2.18 B | USA |
 |
Idera Pharmaceuticals
IDRA
|
158 | - | -23.04 % | $ 26.6 M | USA |
 |
Verona Pharma plc
VRNA
|
136 | - | - | $ 69.7 B |  Britain |
 |
Karuna Therapeutics
KRTX
|
15.9 | - | - | $ 12.2 B | USA |
 |
Curis
CRIS
|
64.7 | $ 0.59 | -9.62 % | $ 7.77 M | USA |
 |
Cyclerion Therapeutics
CYCN
|
137 | $ 34.99 | 3.77 % | $ 147 M | USA |
 |
Fusion Pharmaceuticals
FUSN
|
6 | - | - | $ 1.41 B |  Canada |
 |
Завод ДИОД
DIOD
|
64.6 | - | - | - |  Russia |
 |
Gritstone Oncology
GRTS
|
40.3 | - | 0.42 % | $ 213 M | USA |
 |
Pfizer
PFE
|
312 | $ 29.42 | 0.19 % | $ 167 B | USA |
 |
HOOKIPA Pharma
HOOK
|
3.33 | - | -6.92 % | $ 79.4 M | USA |
 |
Guardion Health Sciences
GHSI
|
217 | - | -0.31 % | $ 3.64 M | USA |
 |
Opiant Pharmaceuticals
OPNT
|
84.9 | - | - | $ 109 M | USA |
 |
Otonomy
OTIC
|
112 | - | -1.96 % | $ 4.68 M | USA |
 |
Prothena Corporation plc
PRTA
|
6.97 | $ 8.74 | 2.1 % | $ 470 M | USA |
 |
Exelixis
EXEL
|
140 | $ 70.73 | 0.21 % | $ 19.2 B | USA |
 |
Aridis Pharmaceuticals
ARDS
|
59 | - | 17.91 % | $ 11.1 M | USA |